Sign In

Co-Occurring Conditions.

HIV Question Bank

Opportunistic Infections: PreventionQuestion 15/15

Questions in Topic

A 54-year-old cisgender man with HIV is seen in the clinic for a follow-up visit. He was diagnosed with HIV about 7 months ago, and a baseline CD4 count was 126 cells/mm3. At that time, he started taking bictegravir-tenofovir alafenamide-emtricitabine and trimethoprim-sulfamethoxazole. In addition, because he lives in a highly endemic region for histoplasmosis, he was started on daily oral itraconazole for prophylaxis.

Which one of the following should be recommended regarding when he could stop itraconazole prophylaxis?

Prev  Skip

Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Question Last Updated
September 28th, 2023

Steps to Acquire CE for this Question Bank Topic:

1

Answer

Answer all questions
2

Score 80%+

Answer correctly
3

Claim CE

Choose CNE or CME
4

Give Feedback

Complete survey
5

Print Certificate

Obtain proof of CE

This question requires improvement because:


Comment further on how to improve this question or summary:



Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.